🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2014-12
Trial ID
NCT01860742
Treatments Being Tested
This is a prospective, open-label, multi-center, non-comparative, non-inter...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-05-10
Trial ID
NCT04946305
Treatments Being Tested
This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-08-27
Trial ID
NCT03457948
Neuroendocrine tumours (NETs) are rare, slow growing, and diagnosis is ofte...
Status
Suspended
Location
Cross Cancer Institute
Start Date
2014-04-29
Trial ID
NCT01876771
Treatments Being Tested
This phase 1 dose-escalation study is designed to evaluate the safety and t...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2021-12-08
Trial ID
NCT05053854
Treatments Being Tested
Lu-DOTA-TATE (Lutetium-177 octreotate) is a radiopharmaceutical that has be...
Status
Unknown
Location
London Health Sciences Centre
Start Date
2014-07
Trial ID
NCT02236910
Treatments Being Tested
The purpose of this study is to learn about the feasibility and safety of u...
Status
Active Not Recruiting
Location
Stanford Cancer Institute Palo Alto
Start Date
2021-03-17
Trial ID
NCT04609592
Treatments Being Tested
The purpose of this study is to determine if 68Gallium-octreotate and 18Flu...
Status
Completed
Location
Jules Bordet Institute
Start Date
2013-05
Trial ID
NCT01842165
Treatments Being Tested
This is a prospective single arm, multicenter study will evaluate the effic...
Status
Active Not Recruiting
Location
Juravinski Cancer Centre
Start Date
2016-07-15
Trial ID
NCT02743741
Treatments Being Tested
This phase I trial tests the safety and effectiveness of stereotactic body ...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2025-10-14
Trial ID
NCT07150546